


The Fund aims to provide capital growth with some income.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 1.3% |
| Royal Dutch Shell PLC | 1.2% |
| BT Group PLC | 1.2% |
| BG Group PLC | 1.1% |
| BP PLC | 1.1% |
| Rolls-Royce Holdings PLC | 0.8% |
| Rio Tinto PLC | 0.8% |
| British American Tobacco PLC | 0.8% |
| Apple Inc. | 0.8% |
| Legal & General Group PLC | 0.8% |
| Key | % Net Assets |
|---|---|
| 1.3% | |
| 1.2% | |
| 1.2% | |
| 1.1% | |
| 95.2% |
| Date | 09-Apr-2021 |
|---|---|
| Bid | 208.50p |
| Offer | 208.50p |
| Currency | GBP |
| Change | 1.00p |
| % | 0.48% |
| YTD change | 208.50p |
| YTD % | n/a |
| Fund Inception | 26/08/1997 |
|---|---|
| Fund Manager | Sarah Arkle / Alex Lyle |
| TER | 1.68 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £2000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 0.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.06 |
You are here: research